Artificial Intelligence Cancer market

Artificial Intelligence (AI) in Cancer Market, Global Outlook and Forecast 2025-2032

  • 05 March 2025
  • Life Sciences
  • 144 Pages
  • Report code : PMR-8034948

  • 4.7 (158)

Artificial Intelligence Cancer Market

COMPANIES COVERED

IBM
Microsoft
NVIDIA
Intel
GE Healthcare
Johnson & Johnson
Cancer Center.ai
Digital Reasoning
Varian Medical Systems
Niramai
Densitas
MammoScreen
MVision AI
Volpara
LungLifeAI

Download FREE Report Sample

  Download Free sample

Report Overview

Integration of AI technology in cancer care could improve the accuracy and speed of diagnosis, aid clinical decision-making, and lead to better health outcomes. AI-guided clinical care has the potential to play an important role in reducing health disparities, particularly in low-resource settings.

The global Artificial Intelligence (AI) in Cancer market size was estimated at USD 1458.30 million in 2023 and is projected to reach USD 2658.56 million by 2032, exhibiting a CAGR of 6.90% during the forecast period.

North America Artificial Intelligence (AI) in Cancer market size was estimated at USD 426.27 million in 2023, at a CAGR of 5.91% during the forecast period of 2025 through 2032.


Artificial Intelligence Cancer Market provides a deep insight into the global Artificial Intelligence (AI) in Cancer market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Artificial Intelligence (AI) in Cancer Market, Artificial Intelligence Cancer Market introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, Artificial Intelligence Cancer Market is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Artificial Intelligence (AI) in Cancer market in any manner.

Global Artificial Intelligence (AI) in Cancer Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

  • IBM
  • Microsoft
  • NVIDIA
  • Intel
  • GE Healthcare
  • Johnson & Johnson
  • Cancer Center.ai
  • Digital Reasoning
  • Varian Medical Systems
  • Niramai
  • Densitas
  • MammoScreen
  • MVision AI
  • Volpara
  • LungLifeAI
Market Segmentation (by Type)
  • Surgery
  • Radiotherapy
  • Chemotherapy
  • Immunotherapy
  • Phototherapy
  • Gene Therapy
  • Sonodynamic Therapy
Market Segmentation (by Application)
  • Diagnosis
  • Therapy
  • Prognosis
  • Health Management
  • Research
Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

FAQs on Artificial Intelligence (AI) in Cancer Market

1. What is the current size of the global AI in Cancer market?

  • The global Artificial Intelligence (AI) in Cancer market was valued at USD 1,458.30 million in 2023 and is expected to grow significantly over the coming years.

2. What is the projected market size of AI in Cancer by 2032?

  • By 2032, the market is forecasted to reach USD 2,658.56 million, growing at a CAGR of 6.90% during the forecast period.

3. How is the North America AI in Cancer market performing?

  • North America’s AI in Cancer market was valued at USD 426.27 million in 2023 and is projected to grow at a CAGR of 5.91% from 2025 to 2032.

4. What are the key drivers of growth in the AI in Cancer market?

The growth of AI in cancer detection, diagnosis, and treatment is driven by:

To know more about market statistics, Download a FREE Sample copy

  • Increasing cancer prevalence worldwide
  • Advancements in AI-powered medical imaging and diagnostics
  • Rising adoption of precision medicine
  • Government initiatives supporting AI in healthcare

5. What are the challenges faced by the AI in Cancer market?

Some key challenges include:

  • High costs of AI-based healthcare solutions
  • Regulatory complexities and approvals
  • Data privacy concerns and ethical considerations in AI-driven diagnostics
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value

CHECK TODAYS BEST PRICE

BEST PRICE: $2275
Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SAMPLE REPORT INCLUDES
  • Industry Market SizeIndustry Market Size
  • SWOT AnalysisSWOT Analysis
  • Industry Major PlayersIndustry Major Players
  • Revenue ForecastsRevenue Forecasts
  • Historical and Forecast GrowthHistorical and Forecast Growth
  • Profitability AnalysisProfitability Analysis
SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Artificial Intelligence Cancer Market

Leave This Empty: